Cairo - Mubasher: Minapharm Pharmaceuticals on Thursday reported a 10.4% year-on-year decrease in consolidated profits for the first nine months of 2018.
Net profit stood at EGP 117.3 million in the January-September period, versus EGP 131.02 million in the year-ago period, the company said in a filing to the Egyptian Exchange (EGX).
Sales grew to EGP 1.5 billion at the end of September from EGP 1.2 billion in the corresponding nine-month period of 2017.
Minapharm previously posted a net profit of EGP 104.4 million in the first half of this year, versus EGP 100.14 million in H1-17.
